Cogent Biosciences, Inc. (COGT)
38.85
-0.61
(-1.55%)
USD |
NASDAQ |
Feb 27, 16:00
38.85
0.00 (0.00%)
After-Hours: 20:00
Cogent Biosciences Research and Development Expense (TTM) : 265.16M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Merck & Co., Inc. | 12.71B |
| Sarepta Therapeutics, Inc. | 1.516B |
| BridgeBio Pharma, Inc. | 451.95M |
| Olema Pharmaceuticals, Inc. | 146.78M |
| Revolution Medicines, Inc. | 978.68M |